UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Primary Therapy of Waldenström Macroglobulinemia With Bortezomib, Dexamethasone, and Rituximab: WMCTG Clinical Trial 05-180

Journal of clinical oncology, 2009-08, Vol.27 (23), p.3830-3835

2009

Volltextzugriff (PDF)

Phase I Trial Using the Proteasome Inhibitor Bortezomib and Concurrent Chemoradiotherapy for Head-and-Neck Malignancies

International journal of radiation oncology, biology, physics, 2012-07, Vol.83 (4), p.1192-1197

2012

Volltextzugriff (PDF)

Perspective on Intradiscal Therapies for Lumbar Discogenic Pain: State of the Science, Knowledge Gaps, and Imperatives for Clinical Adoption

Journal of pain research, 2024-01, Vol.17, p.1171-1182

2024

Volltextzugriff (PDF)

E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases

Investigational new drugs, 2019-08, Vol.37 (4), p.636-645

2019

Volltextzugriff (PDF)

Anti– N -methyl- d -aspartate receptor encephalitis associated with an ovarian teratoma in an adolescent female

Journal of pediatric surgery, 2010-07, Vol.45 (7), p.1550-1553

2010

Volltextzugriff (PDF)

Proteasome inhibitors enhance endothelial thrombomodulin expression via induction of Krüppel-like transcription factors

Arteriosclerosis, thrombosis, and vascular biology, 2009-10, Vol.29 (10), p.1587

2009

Volltextzugriff (PDF)

Phase I trial of aurora kinase A (AURKA) inhibitor VIC-1911 plus osimertinib for TKI-resistant, EGFR-mutant non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8077-8077

2024

Volltextzugriff (PDF)

Proteasome Inhibitors Enhance Endothelial Thrombomodulin Expression via Induction of Krüppel-Like Transcription Factors

Arteriosclerosis, thrombosis, and vascular biology, 2009-10, Vol.29 (10), p.1587-1593

2009

Volltextzugriff (PDF)

A phase 1a/1b study of aurora kinase A inhibitor VIC-1911 as monotherapy and in combination with sotorasib for the treatment of KRAS G12C -mutant non–small-cell lung cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS9140-TPS9140

2023

Volltextzugriff (PDF)

Left Internal Thoracic Artery Graft Occlusion Following Mediastinal Radiation Therapy

Chest, 1994-06, Vol.105 (6), p.1881-1882

1994

Volltextzugriff (PDF)

Building a Leadership Team: An Action Research Study of a High School Administrative Team and Its Work With Teacher Leaders in a New School

Myers, Thomas J

2020

Volltextzugriff (PDF)

Aurora Kinase a Inhibition for Gvhd and Relapse Prevention after Allogeneic HCT: Phase I Trial in Combination with Ptcy/Sirolimus

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S272-S272

2024

Volltextzugriff (PDF)

Glucose Metabolism in Abdominally Obese Hypertensive and Normotensive Subjects

Hypertension (Dallas, Tex. 1979), 1995-07, Vol.26 (1), p.186-192

1995

Volltextzugriff (PDF)

Small cell carcinoma of the larynx and ectopic antidiuretic hormone secretion

Otolaryngology-head and neck surgery, 1995-09, Vol.113 (3), p.301-304

1995

Volltextzugriff (PDF)

Temporal and geomorphic variations of stream stability and morphology: Mahogany Creek, Nevada

Journal of the American Water Resources Association, 1996, Vol.32 (2), p.253-265

1996

Volltextzugriff (PDF)

Impact of Deferred Rotation Grazing on Stream Characteristics in Central Nevada: A Case Study

North American journal of fisheries management, 1995-05, Vol.15 (2), p.428-439

1995

Volltextzugriff (PDF)

Outpatient Treatment with Clofarabine in a Phase II Study of Older Adult Patients with Previously Untreated Acute Myelogenous Leukemia (AML)

Blood, 2009-11, Vol.114 (22), p.4162-4162

2009

Volltextzugriff (PDF)

Bortezomib Improves Endothelial Thromboresistance Via Induction of KLF Transcription Factors

Blood, 2008-11, Vol.112 (11), p.1890-1890

2008

Volltextzugriff (PDF)

Bortezomib, Dexamethasone and Rituximab (BDR) Is a Highly Active Regimen in the Primary Therapy of Waldenstrom's Macroglobulinemia: Planned Interim Results of WMCTG Clinical Trial 05-180

Blood, 2006-11, Vol.108 (11), p.2765-2765

2006

Volltextzugriff (PDF)

Disseminated intravascular coagulation during rewarming following hypothermia

JAMA : the journal of the American Medical Association, 1981-06, Vol.245 (24), p.2517

1981

Volltextzugriff (PDF)

Respiratory failure due to pulmonary leukostasis following chemotherapy of acute nonlymphocytic leukemia

Cancer, 1983-05, Vol.51 (10), p.1808-1813

1983

Volltextzugriff (PDF)

VARIATION OF STREAM STABILITY WITH STREAM TYPE AND LWESTOCK BANK DAMAGE IN NORTHERN NEVADA

Journal of the American Water Resources Association, 1992-08, Vol.28 (4), p.743-754

1992

Volltextzugriff (PDF)

1 – 25 von 1.788

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.590)
Mit Volltextzugriff
(1.447)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.178)
Life Sciences & Biomedicine
(922)
Humans
(743)
Male
(420)
Female
(406)
Biological And Medical Sciences
(347)
Medical Sciences
(297)
Middle Aged
(255)
Adult
(242)
Animals
(228)
Aged
(195)
Physical Sciences
(180)
Technology
(115)
General & Internal Medicine
(106)
Science & Technology - Other Topics
(91)
Risk Factors
(84)
Multidisciplinary Sciences
(82)
Cardiovascular System & Cardiology
(77)
Adolescent
(76)
Medicine, General & Internal
(75)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Primary Therapy of Waldenström Macroglobulinemia With Bortezomib, Dexamethasone, and Rituximab: WMCTG Clinical Trial 05-180

Phase I Trial Using the Proteasome Inhibitor Bortezomib and Concurrent Chemoradiotherapy for Head-and-Neck Malignancies

Perspective on Intradiscal Therapies for Lumbar Discogenic Pain: State of the Science, Knowledge Gaps, and Imperatives for Clinical Adoption

E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases

Phase 1 Results of FF-10501-01, a Novel Inosine 5'-Monophosphate Dehydrogenase Inhibitor, in Advanced Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Hypomethylating Agent (HMA) Failures

Anti– N -methyl- d -aspartate receptor encephalitis associated with an ovarian teratoma in an adolescent female

Proteasome inhibitors enhance endothelial thrombomodulin expression via induction of Krüppel-like transcription factors

Anti-Leukemia Effect of FF-10501-01, a Novel Inosine 5'-Monophosphate Dehydrogenase Inhibitor, in Advanced Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Hypomethylating Agent (HMA) Failures

Phase I trial of aurora kinase A (AURKA) inhibitor VIC-1911 plus osimertinib for TKI-resistant, EGFR-mutant non-small cell lung cancer (NSCLC)

Proteasome Inhibitors Enhance Endothelial Thrombomodulin Expression via Induction of Krüppel-Like Transcription Factors

A phase 1a/1b study of aurora kinase A inhibitor VIC-1911 as monotherapy and in combination with sotorasib for the treatment of KRAS G12C -mutant non–small-cell lung cancer

Left Internal Thoracic Artery Graft Occlusion Following Mediastinal Radiation Therapy

Building a Leadership Team: An Action Research Study of a High School Administrative Team and Its Work With Teacher Leaders in a New School

Aurora Kinase a Inhibition for Gvhd and Relapse Prevention after Allogeneic HCT: Phase I Trial in Combination with Ptcy/Sirolimus

Glucose Metabolism in Abdominally Obese Hypertensive and Normotensive Subjects

Small cell carcinoma of the larynx and ectopic antidiuretic hormone secretion

Temporal and geomorphic variations of stream stability and morphology: Mahogany Creek, Nevada

Impact of Deferred Rotation Grazing on Stream Characteristics in Central Nevada: A Case Study

Outpatient Treatment with Clofarabine in a Phase II Study of Older Adult Patients with Previously Untreated Acute Myelogenous Leukemia (AML)

Bortezomib Improves Endothelial Thromboresistance Via Induction of KLF Transcription Factors

Bortezomib, Dexamethasone and Rituximab (BDR) Is a Highly Active Regimen in the Primary Therapy of Waldenstrom's Macroglobulinemia: Planned Interim Results of WMCTG Clinical Trial 05-180

The Schedule Dependent Combination of Bortezomib (Bor) with Rituximab (R), Cyclophosphamide (C) and Prednisone (P) Produces Minimal Toxicity, Even at Relatively High Doses of Proteasome Inhibitor, in Patients with Relapsed/Refractory Indolent B-Cell Lymphomproliferative Disorders

Disseminated intravascular coagulation during rewarming following hypothermia

Respiratory failure due to pulmonary leukostasis following chemotherapy of acute nonlymphocytic leukemia

VARIATION OF STREAM STABILITY WITH STREAM TYPE AND LWESTOCK BANK DAMAGE IN NORTHERN NEVADA

Suchergebnisse filtern